Esaote yesterday announced it was acquired by a consortium of Chinese investors composed of several major companies in the medical field and investment funds.
Genoa, Italy-based Esaote produces medical devices with a focus on ultrasound, dedicated magnetic resonance imaging and diagnostic management software.
The acquiring consortium includes Chinese medical equipment maker Wandong, private equity fund Yufeng Capital, Chinese free trade zone fund Shanghai FTZ Fund, investment group Tianyi, Chinese home medical equipment maker holding company Yuyue and OEM manufacturer Kangda.
Esaote said that with the acquisition, it will accelerate development plans with a focus on growth projects in China, though the company will continue to operate as an independent international company with headquarters in Italy and R&D facilities in Italy and the Netherlands, according to a press release.
Last October, Esaote announced the launch of its MyLab 9 platform.
Early rates for DeviceTalks Boston end August 15th.
Don't miss the chance to save $100 and join top medtech innovators including leaders from Hologic, Google, Gray Matter, TransEnterix, NxStage Medical, Smith & Nephew, HeartFlow, Dynatronics, Johnson & Johnson, Allied Minds, and many more.
View Full Agenda
Register today to save. Use code LASTCALL to save an additional 10%.